Research Stories

New OSUCCC – James CEO Commends Community’s Devotion to Research

| September 19, 2025

W. Kimryn Rathmell, MD, PhD, the new CEO of Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James) marked her inaugural Pelotonia Ride Weekend with both a personal milestone and a vivid introduction to the vibrant, purpose-driven community fueling cancer research.

At Opening Ceremony, she stood before tens of thousands, immersing herself in the energy that defines Pelotonia, and then joined the more than 2,700 participants riding the 24-mile route on Saturday. Her experience underscored the profound partnership between the community and the groundbreaking cancer research led by the OSUCCC – James. 

Dr. Rathmell spoke passionately about how critical Pelotonia’s support is for translating innovative science into real-world impact.

She emphasizes, “I can’t overstate how important the impact of Pelotonia’s support is on our cancer research. We do more innovative, more exciting and more powerful research because the community is behind us.”

These words reflect a core truth: while cutting-edge science is foundational to progress, it is the unwavering engagement, generosity and spirit of the Pelotonia community that helps fuel and accelerate breakthroughs at the OSUCCC – James. 

Having previously served as director of the National Cancer Institute, she found Ohio State distinctly and deeply aligned with her passion — a synergy of discovery, compassionate patient care and community connection. She highlighted how the OSUCCC – James is uniquely poised to lead cancer research, treatment and prevention, thanks to the combined talents of researchers, clinicians and an engaged community that rallies together around a common purpose. 

Dr. Rathmell described Pelotonia not simply as a fundraiser but as a movement with global reach. The people who join the ride — cancer survivors, families, scientists, caregivers, donors and volunteers — form a dynamic network whose shared commitment elevates the OSUCCC – James’ mission. This collective engagement shapes the research agenda itself, ensuring that it addresses real-world needs and fosters hope for all impacted by cancer. 

Dr. Rathmell rode alongside participants during Ride Weekend, experiencing first-hand what it means to connect with the people and the mission driving Pelotonia.

Reflecting after finishing her first ride, she says, “I am energized. This is a tremendous experience.” Her participation exemplified the unity and purpose that fuel the community.

“Choosing to ride in Pelotonia helps to see the power that there is in coming together around something as important as cancer.”

This shared journey between researchers, clinicians, patients and supporters is what propels the science and care forward. 

Beyond the event itself, Dr. Rathmell’s leadership vision hinges on deepening the connection between science and community. She believes that innovation thrives when informed by the stories and needs of those who face cancer. This approach not only shapes research priorities but also builds trust and hope in the broader community. Her goal is clear: to ensure research discoveries translate into accessible, effective care that improves outcomes for all. 

In her role, Dr. Rathmell also carries the responsibility of mentoring and building the next generation of cancer scientists and clinicians. She has spoken about the importance of guidance in navigating the complexities of medical and scientific careers and the value of nurturing diverse talent committed to the mission of reducing cancer’s toll. 

Her excitement about Ohio State’s cancer program is grounded in both its cutting-edge capabilities and its location at the cultural crossroads of rural, urban and diverse populations in Ohio. The OSUCCC – James is positioned to address disparities in cancer outcomes and develop prevention, detection and treatment that benefit broad communities. 

Dr. Rathmell envisions a future where cancer prevention is widespread, early detection is accessible and new treatments mitigate suffering. “Ultimately, it will be a world where people don’t fear cancer the way we do today,” she says.  

Dr. Rathmell’s first Ride Weekend embodied this spirit — standing shoulder to shoulder with riders and supporters, embracing the community and stepping into a leadership approach that blends scientific expertise with heartfelt commitment. Her arrival marks a new chapter for OSUCCC – James, one driven by innovation, collaboration and the unstoppable force of a community united in ending cancer. 

Funding Partners

Thanks to our generous funding partners

100% of every participant-raised dollar goes to innovative cancer research at the OSUCCC – James.